Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice

Behavioural Brain Research

Volumn 209, Issue 1, 2010, Pages 59-65

  Frye, Cheryl A ^a   Sora, Ichiro ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Affect; Estrogen; Hippocampus; Neurosteroid; Reproductive experience

Indexed keywords

DOPAMINE RECEPTOR; PROGESTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HYPERACTIVITY; KNOCKOUT MOUSE; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; RESPONSE TIME; SCHIZOPHRENIA; SEX DIFFERENCE; TREATMENT RESPONSE; WILD TYPE;

ACOUSTIC STIMULATION; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HYPERKINESIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PROGESTERONE; PROGESTINS; STARTLE REACTION;

EID: 77249179149     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.01.015     Document Type: Article

References (60)

1. Castner S.A., Goldman-Rakic P.S., and Williams G.V. Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berl) 174 (2004) 111-125
2. Cooper D.C. The significance of action potential bursting in the brain reward circuit. Neurochem Int 41 (2002) 333-340
3. Dazzi L., Serra M., Seu E., Cherchi G., Pisu M.G., Purdy R.H., et al. Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride. J Neurochem 83 (2002) 1103-1109
4. Dong E., Matsumoto K., Uzunova V., Sugaya I., Takahata H., Nomura H., et al. Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci 98 (2001) 2849-2854
5. Dulawa S.C., Hen R., Scearce-Levie K., and Geyer M.A. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology 132 (1997) 125-134
6. Frye C.A. Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacol Biochem Behav 86 (2007) 209-219
7. Frye C.A., and Bayon L.E. Mating stimuli influence endogenous variations in the neurosteroids 3α,5α-THP and 3α-Diol. J Neuroendocrinol 11 (1999) 839-847
8. Frye C.A., Duffy C.K., and Walf A.A. Estrogens and progestins enhance spatial learning of intact and ovariectomized rats in the object placement task. Neurobiol Learn Mem 88 (2007) 208-216
9. Frye C.A., and Edinger K.L. Testosterone's metabolism in the hippocampus may mediate its anti-anxiety effects in male rats. Pharmacol Biochem Behav 78 (2004) 473-481
10. Frye C.A., and Lacey E.H. Progestins influence performance on cognitive tasks independent of changes in affective behavior. Psychobiology 28 (2000) 550-563
11. Frye C.A., and Seliga A.M. Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats. Psychoneuroendocrinology 28 (2003) 657-673
12. Frye C.A., Sumida K., Dudek B.C., Harney J.P., Lydon J.P., O'Malley B.W., et al. Progesterone's effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology 186 (2006) 312-322
13. Frye C.A., Sumida K., Lydon J.P., O'Malley B.W., and Pfaff D.W. Mid-aged and aged wild-type and progestin receptor knockout (PRKO) mice demonstrate rapid progesterone and 3α,5α-THP-facilitated lordosis. Psychopharmacology 185 (2006) 423-432
14. Frye C.A., Walf A.A., Rhodes M.E., and Harney J.P. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5α-reductase. Brain Res 1004 (2004) 116-124
15. Geyer M.A., and Dulawa S.C. Assessment of murine startle reactivity, prepulse inhibition, and habituation. In: Crawley J., and Gerfen C. (Eds). Current protocols in neuroscience (2003), John Wiley & Sons Inc., New Jersey 8171-8215
16. Gizerian S.S., Morrow A.L., Lieberman J.A., and Grobin A.C. Neonatal neurosteroid administration alters parvalbumin expression and neuron number in medial dorsal thalamus of adult rats. Brain Res 1012 (2004) 66-74
17. Grobin A.C., Gizerian S., Lieberman J.A., and Morrow A.L. Perinatal allopregnanolone influences prefrontal cortex structure, connectivity and behavior in adult rats. Neuroscience 138 (2006) 809-819
18. Häfner H., Riecher-Rössler A., Maurer K., Fätkenheuer B., and Löffler W. First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. Eur Arch Psychiatry Clin Neurosci 242 (1992) 109-118
19. Hallonquist J.D., Seeman M.V., Lang M., and Rector N.A. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 33 (1993) 207-209
20. Hendrick V., Altshuler L.L., and Burt V.K. Course of psychiatric disorders across the menstrual cycle. Harv Rev Psychiatry 4 (1996) 200-207
21. Holzbauer M. Physiological variations in the ovarian production of 5α-pregnane derivatives with sedative properties in the rat. J Steroid Biochem 6 (1975) 1307-1310
22. Hornykiewicz O. Neurohumoral interactions and basal ganglia function and dysfunction. Res Publ Assoc Res Nerv Ment Dis 55 (1976) 269-280
23. Huber T.J., Rollnik J., Wilhelms J., von zur Mühlen A., Emrich H.M., and Schneider U. Estradiol levels in psychotic disorders. Psychoneuroendocrinology 26 (2001) 27-35
24. Jung-Testas I., Renoir M., Bugnard H., Greene G.L., and Baulieu E.E. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Mol Biol 41 (1992) 621-631
25. Laruelle M., Kegeles L.S., and Abi-Dargham A. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 1003 (2003) 138-158
26. Leung A., and Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 401 (2000) 3-38
27. Liddle P.F. Cognitive impairment in schizophrenia: its impact on social functioning. Acta Psychiatr Scand Suppl 400 (2000) 11-16
28. Lukoff D., Snyder K., Ventura J., and Nuechterlein K.H. Life events, familial stress, and coping in the developmental course of schizophrenia. Schizophr Bull 10 (1984) 258-292
29. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
30. Malla A.K., Cortese L., Shaw T.S., and Ginsberg B. Life events and relapse in schizophrenia. A one year prospective study. Soc Psychiatr Epidemiol 25 (1990) 221-224
31. Marx C.E., Duncan G.E., Gilmore J.H., Lieberman J.A., and Morrow A.L. Olanzapine increases allopregnanolone in the rat cerebral cortex. Biol Psychiatry 47 (2000) 1000-1004
32. Marx C.E., Keefe R.S., Buchanan R.W., Hamer R.M., Kilts J.D., Bradford D.W., et al. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology 34 (2009) 1885-1903
33. Morice E., Billard J.M., Denis C., Mathieu F., Betancur C., Epelbaum J., et al. Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology 32 (2007) 2108-2116
34. Muneoka K.T., Shirayama Y., Minabe Y., and Takigawa M. Effects of a neurosteroid, pregnenolone, during the neonatal period on adenosine A1 receptor, dopamine metabolites in the fronto-parietal cortex and behavioral response in the open field. Brain Res 956 (2002) 332-338
35. Muneoka K.T., and Takigawa M.A. Neuroactive steroid, pregnenolone, alters the striatal dopaminergic tone before and after puberty. Neuroendocrinology 75 (2002) 288-295
36. Myin-Germeys I., van Os J., Schwartz J.E., Stone A.A., and Delespaul P.A. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 58 (2001) 1137-1144
37. Newcomer J.W., Faustman W.O., Whiteford H.A., Moses Jr. J.A., and Csernansky J.G. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biol Psychiatry 29 (1991) 855-864
38. Norman R.M., and Malla A.K. Stressful life events and schizophrenia. I: a review of the research. Br J Psychiatry 162 (1993) 161-166
39. Patchev V.K., Hassan A.H., Holsboer D.F., and Almeida O.F. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15 (1996) 533-540
40. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 (1992) 2311-2322
41. Pisu M.G., and Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci 74 (2004) 3181-3197
42. Pomata P.E., Colman-Lerner A.A., Barañao J.L., and Fiszman M.L. In vivo evidences of early neurosteroid synthesis in the developing rat central nervous system and placenta. Dev Brain Res 120 (2000) 83-86
43. Powell S.B., Young J.W., Ong J.C., Caron M.G., and Geyer M.A. Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behav Pharmacol 19 (2008) 562-565
44. Prata D.P., Mechelli A., Picchioni M.M., Fu C.H., Toulopoulou T., Bramon E., et al. Altered effect of dopamine transporter 3′UTR VNTR genotype on prefrontal and striatal function in schizophrenia. Arch Gen Psychiatry 66 (2009) 1162-1172
45. Purdy R.H., Morrow A.L., Moore Jr. P.H., and Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci 88 (1991) 4553-4557
46. Read J., Perry B.D., Moskowitz A., and Connolly J. The contribution of early traumatic events to schizophrenia in some patients: a traumagenic neurodevelopmental model. Psychiatry 64 (2001) 319-345
47. Rhodes M.E., and Frye C.A. Estrogen has mnemonic-enhancing effects in the inhibitory avoidance task. Pharmacol Biochem Behav 78 (2004) 551-558
48. Rhodes M.E., and Frye C.A. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cogn Affect Behav Neurosci 1 (2001) 287-296
49. Ritsner M., Maayan R., Gibel A., and Weizman A. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects. Eur Neuropsychopharmacol 17 (2007) 358-365
50. Schultz S.K., and Andreasen N.C. Schizophrenia. Lancet 353 (1999) 1425-1430
51. Seeman M.V. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154 (1997) 1641-1647
52. Shen H.W., Hagino Y., Kobayashi H., Shinohara-Tanaka K., Ikeda K., and Yamamoto H. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29 (2004) 1790-1799
53. Shirayama Y., Hashimoto K., Suzuki Y., and Higuchi T. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophr Res 58 (2002) 69-74
54. Sora I., Kobayashi H., and Numachi Y. Genetically modified animals as models for psychiatric diseases. Seishin Shinkeigaku Zasshi 107 (2005) 285-289
55. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci 95 (1998) 7699-7704
56. Sumida K., Walf A.A., and Frye C.A. Progestin-facilitated lordosis of hamsters may involve dopamine-like type 1 receptors in the ventral tegmental area. Behav Brain Res 161 (2005) 1-7
57. Tandon R., Ribeiro S.C., DeQuardo J.R., Goldman R.S., Goodson J., and Greden J.F. Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: a replication. Biol Psychiatry 34 (1993) 495-497
58. Walf A.A., Rhodes M.E., and Frye C.A. Ovarian steroids enhance object recognition in naturally cycling and ovariectomized, hormone-primed rats. Neurobiol Learn Mem 86 (2006) 35-46
59. Walker E.F., and Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol Rev 104 (1997) 667-685
60. Yamashita M., Fukushima S., Shen H.W., Hall F.S., Uhl G.R., Numachi Y., et al. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology 31 (2006) 2132-2139